Minimising Vaccine-Preventable Conditions in Adult Patients with Chronic Lung Disease
For RACGP Members: This education is a CPD Activity under the RACGP CPD Program. Activity ID: 450447.
For ACCRM Members: This education is a CPD-accredited Activity under the ACRRM PDP Program. Activity ID: 29468.
For APNA members: This education has been endorsed by APNA. Activity ID: C21514
For APC members: This activity has been accredited for 2 hrs of Group 1 CPD (or 2 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 2 hrs of Group 2 CPD (or 4 CPD credits) upon successful completion of relevant assessment activities. Accreditation Number: A2304LC1 Pharmacist Competencies: 1.5, 2.1, 3.1, 3.2, 3.5, 3.6, 5.3
Learning Objectives
Describe the rationale for updating vaccinations in patients with chronic lung disease
Discuss the consequences of undervaccination in patients with asthma and COPD.
Recommend appropriate immunisations for patients with chronic lung disease.
For APC members, The 2016 Competency Standards addressed by this activity include:
1.5: Apply expertise in professional practice 2.1: Collaborate and work in partnership for the delivery of patient centred, culturally responsive care 3.1: Develop a patient centred, culturally responsive approach to medication management Implement the medication management strategy or plan 3.5: Support Quality Use of Medicines 3.6:Promote health and well-being 5.3:Research, synthesise and integrate evidence into practice
Previous
Next
This education module was developed by Lateral Connections at the request of, and with funding from, GlaxoSmithKline Australia Pty Ltd ABN 47 100 162 481. Melbourne, VIC. NX-AU-AVU-OGM-230005, Date of Approval May 2023.